Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Sopharma (BGSFA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
6.040 -0.060    -0.98%
06:00:00 - Closed. Currency in BGN ( Disclaimer )
  • Volume: 7,964
  • Bid/Ask: 3.940 / 3.990
  • Day's Range: 6.040 - 6.100
Type:  Equity
Market:  Bulgaria
ISIN:  BG11SOSOBT18 
Sopharma AD 6.040 -0.060 -0.98%

BGSFA Balance Sheet

 
Assess the latest Sopharma AD balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced BGSFA Annual Report data, financial summaries and charts are available for Sopharma investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 781.89 729.49 653.96 621.37
Cash and Short Term Investments 128.88 17.43 16.99 19.64
Cash - - - -
Cash & Equivalents 128.88 17.43 16.99 19.64
Short Term Investments - - - -
Total Receivables, Net 311.93 384.85 305.23 290.44
Accounts Receivables - Trade, Net 283.83 287.63 281.22 266.98
Total Inventory 331.44 311.6 315.93 296
Prepaid Expenses 2.73 2.67 2.8 2.47
Other Current Assets, Total 6.91 12.94 13.01 12.82
Total Assets 1509.89 1439.57 1349.2 1311.71
Property/Plant/Equipment, Total - Net 357.36 363.22 370.18 374.54
Property/Plant/Equipment, Total - Gross 682.1 683.13 678.83 679.31
Accumulated Depreciation, Total -324.74 -319.91 -308.64 -304.77
Goodwill, Net 3.44 3.53 3.49 3.5
Intangibles, Net 57.72 45.35 46.31 47.18
Long Term Investments 235.5 226.08 182.58 175.04
Note Receivable - Long Term 16.9 85.99 12.84 12.34
Other Long Term Assets, Total 19.68 19.39 19.26 19.01
Other Assets, Total 91.91 3.43 108.29 100.57
Total Current Liabilities 607.71 575.3 509.72 430.9
Accounts Payable 188 154.3 165.01 179.43
Payable/Accrued - - - -
Accrued Expenses 29.83 26.06 26.67 25.56
Notes Payable/Short Term Debt 200.48 278.59 199.56 164.81
Current Port. of LT Debt/Capital Leases 23.17 20.31 21.73 24.34
Other Current liabilities, Total 166.24 96.04 96.76 36.77
Total Liabilities 757.08 708.19 637.68 562.06
Total Long Term Debt 126.88 109.08 96.31 99.47
Long Term Debt 55.53 37.77 23.45 29.44
Capital Lease Obligations 71.35 71.32 72.86 70.03
Deferred Income Tax 3.67 5.39 5.82 5.84
Minority Interest 15.27 14.96 14.18 13.36
Other Liabilities, Total -206.47 -287.43 -203.54 -170.3
Total Equity 752.81 731.38 711.52 749.65
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 172.59 134.8 134.8 134.8
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 579.35 588.19 571.72 606.93
Treasury Stock - Common -57.45 -52.2 -52.2 -52.2
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 58.32 60.6 57.2 60.13
Total Liabilities & Shareholders' Equity 1509.89 1439.57 1349.2 1311.71
Total Common Shares Outstanding 159.11 121.32 121.32 121.32
Total Preferred Shares Outstanding - - - -
* In Millions of BGN (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BGSFA Price Commentary

Write your thoughts about Sopharma
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email